-
公开(公告)号:US20090162375A1
公开(公告)日:2009-06-25
申请号:US11924108
申请日:2007-10-25
申请人: Simon Blake , Jill Carton , Jennifer Henrica Lee , Keying Ma , Paul Marsters , Kristen Picha , Xiao-Yu R. Song , Francis Farrell , Lynne Murray , Alexey Teplyakov , Tatiana Ort
发明人: Simon Blake , Jill Carton , Jennifer Henrica Lee , Keying Ma , Paul Marsters , Kristen Picha , Xiao-Yu R. Song , Francis Farrell , Lynne Murray , Alexey Teplyakov , Tatiana Ort
IPC分类号: A61K39/395 , C07K16/26 , C07K7/08 , C07H21/00 , C12Q1/02
CPC分类号: C07K16/26 , C07K2317/34 , C07K2317/76 , C07K2317/92
摘要: Resistin antagonists, including antibodies reactive with defined epitopes, are disclosed. Antigens useful for raising antibodies against human resistin are also disclosed. Methods of utilizing resistin antagonists to treat or alleviate the symptoms of the diseases with aberrant fibroblast activity including interstitial lung diseases, hypertrophic scarring, keloid scarring and scleroderma are also disclosed. Methods of utilizing resistin as a biomarker to diagnose the risk and/or progression of osteoarthritis are also disclosed. Further disclosed are methods of utilizing the antagonists to treat or alleviate the symptoms of osteoarthritis.
摘要翻译: 公开了抗性拮抗剂,包括与限定的表位反应的抗体。 还公开了可用于提高抗人抵抗素抗体的抗原。 还公开了利用抵抗素拮抗剂治疗或缓解具有异常成纤维细胞活性(包括间质性肺病,肥大性瘢痕形成,瘢痕疙瘩瘢痕形成和硬皮病)的疾病症状的方法。 还公开了利用抗性蛋白作为生物标志物来诊断骨关节炎的风险和/或进展的方法。 进一步公开的是利用拮抗剂治疗或减轻骨关节炎症状的方法。
-
公开(公告)号:US20110071277A1
公开(公告)日:2011-03-24
申请号:US12722950
申请日:2010-03-12
申请人: Simon Blake , Jill Carton , Jennifer Henrica Lee , Keying Ma , Paul Marsters , Kristen Picha , Xiao-Yu R. Song , Francis Farrell , Lynne Murray , Alexey Teplyakov , Tatiana Ort
发明人: Simon Blake , Jill Carton , Jennifer Henrica Lee , Keying Ma , Paul Marsters , Kristen Picha , Xiao-Yu R. Song , Francis Farrell , Lynne Murray , Alexey Teplyakov , Tatiana Ort
IPC分类号: C07K16/00
CPC分类号: C07K16/26 , C07K2317/34 , C07K2317/76 , C07K2317/92
摘要: Resistin antagonists, including antibodies reactive with defined epitopes, are disclosed. Antigens useful for raising antibodies against human resistin are also disclosed. Methods of utilizing resistin antagonists to treat or alleviate the symptoms of the diseases with aberrant fibroblast activity including interstitial lung diseases, hypertrophic scarring, keloid scarring and scleroderma are also disclosed. Methods of utilizing resistin as a biomarker to diagnose the risk and/or progression of osteoarthritis are also disclosed. Further disclosed are methods of utilizing the antagonists to treat or alleviate the symptoms of osteoarthritis.
摘要翻译: 公开了抵抗素拮抗剂,包括与限定的表位反应的抗体。 还公开了可用于提高抗人抵抗素抗体的抗原。 还公开了利用抵抗素拮抗剂治疗或缓解具有异常成纤维细胞活性(包括间质性肺病,肥大性瘢痕形成,瘢痕疙瘩瘢痕形成和硬皮病)的疾病症状的方法。 还公开了利用抗性蛋白作为生物标志物来诊断骨关节炎的风险和/或进展的方法。 进一步公开的是利用拮抗剂治疗或减轻骨关节炎症状的方法。
-